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Abstract
Objective To determine whether antibiotic prophylaxis at the time of
removal of a urinary catheter reduces the risk of subsequent symptomatic
urinary tract infection.
Design Systematic review and meta-analysis of studies published before
November 2012 identified through PubMed, Embase, Scopus, and the
Cochrane Library; conference abstracts for 2006-12 were also reviewed.
Inclusion criteria Studies were included if they examined antibiotic
prophylaxis administered to prevent symptomatic urinary tract infection
after removal of a short term (≤14 days) urinary catheter.
Results Seven controlled studies had symptomatic urinary tract infection
after catheter removal as an endpoint; six were randomized controlled
trials (five published; one in abstract form) and one was a
non-randomized controlled intervention study. Five of these seven studies
were in surgical patients. Studies were heterogeneous in the type and
duration of antimicrobial prophylaxis and the period of observation.
Overall, antibiotic prophylaxis was associated with benefit to the patient,
with an absolute reduction in risk of urinary tract infection of 5.8%
between intervention and control groups. The risk ratio was 0.45 (95%
confidence interval 0.28 to 0.72). The number needed to treat to prevent
one urinary tract infection was 17 (12 to 30).
Conclusions Patients admitted to hospital who undergo short term
urinary catheterization might benefit from antimicrobial prophylaxis when
the catheter is removed as they experience fewer subsequent urinary
tract infections. Potential disadvantages of more widespread antimicrobial
prophylaxis (side effects and cost of antibiotics, development of
antimicrobial resistance) might be mitigated by the identification of which
patients are most likely to benefit from this approach.

Introduction
Urinary catheterization is common in patients in hospital,
particularly for surgical patients in the perioperative period
when physiological mechanisms of bladder emptying are
suspended. Catheterization of the urinary tract, however, is
associated with an increased risk of bacteriuria and symptomatic
urinary tract infection, the risk being associated with the duration
of catheterization.1 National guidelines recommend removal of
urinary catheters once they are no longer needed,2-4 and surgical
experts advocate discontinuation of catheterization as early as
24-48 hours postoperatively.5 Bacteriuria in a patient with a
catheter, however, can persist after the catheter is removed and
can develop into a symptomatic urinary tract infection.
Manipulation of the catheter itself during removal might also
predispose to infection.6 Current definitions‘ from the National
Healthcare Safety Network (NHSN) for catheter associated
urinary tract infection (CAUTI) reflect this by identifying
infections up to 48 hours after catheter removal as catheter
associated (www.cdc.gov/nhsn/pdfs/pscmanual/7psccauticurrent.
pdf).3
Whether administration of prophylactic antibiotics when the
catheter is removed will prevent subsequent symptomatic urinary
tract infection is unclear. Randomized trials have yielded
conflicting results,7 8 and there has been no meta-analysis. Also,
there is considerable heterogeneity in the management of
antimicrobial prophylaxis around removal of a urinary catheter.9
The 2009 Infectious Diseases Society of America (IDSA)
guidelines for the diagnosis, management, and prevention of
catheter associated urinary tract infection determined that there
was insufficient evidence to recommend widespread antibiotic
prophylaxis after catheterization.2 In contrast, in their 2008 best
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practice policy statement the American Urological Association
(AUA) concluded that antibiotic prophylaxis should be
considered for patients with bacteriuria at time of catheter
removal, particularly for those with certain risk factors (such
as advanced age, immunodeficiency, or anatomic abnormalities
of the urinary tract).10
We performed a meta-analysis of controlled trials to clarify
whether antibiotic prophylaxis at the time of urinary catheter
removal confers a benefit in terms of preventing subsequent
symptomatic urinary tract infections.

Methods

Search strategy and selection criteria
We followed the PRISMA guidelines for conducting and
reporting meta-analyses.11 We did two separate queries. First,
we performed a systematic review of randomized and
non-randomized controlled trials that compared antibiotic
prophylaxis with placebo or a control group at the time of
removal of a transurethral urinary catheter and tracked the
occurrence of symptomatic urinary tract infections in the
subsequent period (JM). For this purpose, we screened the
medical literature in PubMed from 1947 up to November 2012
with the search terms urinary catheter, removal, prophylaxis,
antibiotic prophylaxis randomized, and trial, and evaluated
conference abstracts from 2006-2012 (from Infectious Diseases
Society of America (IDSA) annual meeting, Interscience
Conference on Antimicrobial Agents and Chemotherapy
(ICAAC), Society for Healthcare Epidemiology of America
(SHEA) annual meeting, and the European Congress of Clinical
Microbiology and Infectious Diseases (ECCMID)). In addition,
we used Google to search for the same terms. Next, a medical
librarian (SF) created a systematic search strategy that included
a combination of standardized index terms and straight
keywords. She ran that search in Embase, Scopus, the Cochrane
Library (including CENTRAL), and clinicaltrials.gov, in
addition to PubMed. We reviewed the reference lists of all
potentially relevant studies to identify additional research data.
We included non-English language and unpublished studies (fig
1).⇓
Eligible studies were randomized and non-randomized controlled
trials of short term catheterization in adults with symptomatic
urinary tract infection as an endpoint. We defined short term
catheterization as a maximum duration of 14 days. The endpoint
of symptomatic urinary tract infection required the detection of
measureable bacteriuria plus the presence of at least one
symptom or sign compatible with urinary tract infection.2 Not
all studies, however, specified which clinical criteria were
fulfilled for this endpoint. We did not include the endpoint
bacteriuria because antibiotic treatment of asymptomatic
bacteriuria is not indicated.12 Because antibiotic prophylaxis
was directed specifically at the prevention of symptomatic
urinary tract infections, we did not assess additional outcomes
such as survival. Subsequent symptomatic urinary tract
infections caused by antibiotic resistant organisms would have
been a meaningful secondary endpoint but none of the included
studies assessed it.
One reviewer (JM) screened the titles and abstracts of eligible
studies originating from the primary search. Two independent
reviewers (JM, BWT) screened the titles and abstracts of eligible
studies identified in the secondary search. Potentially relevant
papers were obtained, and these reviewers assessed the full
manuscript for possible inclusion. There were no restrictions
with regard to the antibiotics used for prophylaxis or the length
of follow-up after antibiotic prophylaxis in the reviewed studies.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions

Data extraction and meta-analysis
We extracted information about the study design, inclusion
criteria for patients, sample size, antimicrobial agents used for
prophylaxis, and the duration of administration. We also noted
the duration of catheterization until removal in intervention and
control groups. Finally, we extracted the number of endpoints
in intervention and control groups in relation to the patients
assigned to each of the groups.

We assessed the internal validity of individual trials using a
modification of the Cochrane Handbook quality assessment
recommendations.13 Two investigators (JM, CRC) independently
rated each trial across four domains of bias: selection,
performance, attrition, and detection. A priori, both investigators
agreed to evaluate selection bias based on adequacy of
randomization and allocation concealment for each study, while
performance bias was judged on the probability for systematic
differences in care after randomization. Investigators judged
attrition bias based on any systematic difference in withdrawals
between intervention and control groups. Detection bias was
assessed on the timing and methods used to ascertain the primary
outcome for each study. The reliability of quality assessment
between raters was evaluated with Cohen’s κ,14 with the
statistical package SPSS version 20 (IBM Corporation, Armonk,
NY). Discrepancies between raters were resolved by consensus.
All data were entered into the free online analysis tool
“Meta-Analyst” (http://tuftscaes.org/meta_analyst/).
Heterogeneity among the studies was assessed with χ2 and I2
statistics (25%, 50%, and 75% representing low, moderate, and
high heterogeneity).15 We pooled the results of studies using
random effects models, if appropriate, after consideration of
heterogeneity among trials. We calculated individual and pooled
statistics as relative risks and 95% confidence intervals. We
conducted a sensitivity analysis of the pooled relative risk by
sequentially excluding the non-randomized study and the
unpublished study from the analysis. We also performed
subgroup analyses of studies in surgical patients and mixed
hospital populations. We evaluated potential publication bias
with a funnel plot.16

Results
The two literature searches identified 246 and 221 potentially
relevant abstracts (fig 1⇓). In the primary search, we identified
27 abstracts that led to full article review and two further studies
by reviewing bibliographies or through conference abstracts.
In the secondary search, two reviewers independently
determined that 17 of 221 abstracts required review of the full
manuscript. After review, we excluded studies in which the
patients had suprapubic catheters,17 18 the endpoint was not
symptomatic bacteriuria,19-21 or antibiotic prophylaxis was started
shortly after catheter insertion rather than at the time of
removal.22 23 We also excluded studies that lacked a concurrent
control group.24 Seven studies met eligibility criteria.
This meta-analysis includes five published randomized
controlled trials,7 8 25-27 one unpublished randomized controlled
trial,28 and one non-randomized controlled study29 (table 1⇓).
Three trials indicated that prophylaxis is associated with lower
incidence of urinary tract infection,7 26 29 whereas three published
studies8 25 27 and the single unpublished randomized study28 did
not report any benefit with prophylaxis. The quality of the
included studies was variable: there was a low risk of detection
bias and performance bias and a high risk of selection and
attrition bias in most studies. Specifically, randomization and
adequate allocation were inadequate in all studies except those
Subscribe: http://www.bmj.com/subscribe
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by Wazait and colleagues,27 Pfefferkorn and colleagues,7 and
van Hees and colleagues.8

Attrition bias was a concern across all of the studies except
those by Wazait and colleagues27 and van Hees and colleagues.8
The inter-rater κ to describe study quality was between 0.7
(attrition bias) and 1.0 (selection and performance bias). For
the detection bias, we could not calculate κ because one rater’s
assessment was constant across studies (that is, κ=0). Both raters
resolved all discrepancies and achieved consensus (table 2).⇓

Sample size calculations were missing for some studies,25-27 and
the calculations were based on the endpoint bacteriuria rather
than symptomatic urinary tract infection for another study.8 One
study did not achieve the required sample size.7 On the other
hand, there were no missing data and no crossovers were
reported.

The conference abstract of an unpublished study described a
randomized controlled trial from the Netherlands.28 In this study,
288 patients were randomized to either nitrofurantoin
prophylaxis or placebo at time of catheter removal. Symptomatic
urinary tract infections occurred in 18/151 (11.9%) of the
intervention group and 12/137 (8.8%) of the control group; these
rates were not significantly different. The one non-randomized
prospective study evaluated antibiotic prophylaxis in 729
consecutive patients who underwent laparoscopic radical
prostatectomy. In this study, patients were given antibiotic
prophylaxis (a three day course of ciprofloxacin starting the day
before catheter removal) if they were seen by surgeon A or no
prophylaxis if the procedure was done by surgeon B.29 Fewer
patients in the intervention group experienced urinary tract
infections (3.1% v 7.3%; P=0.02). Additionally, the numbers
of urinary tract infections in the various arms in the study
reported by Harding and colleagues26 were difficult to discern
from the published text and were therefore confirmed via email
with one of Harding’s coauthors (L Nicolle, personal
communication). Five out of seven included studies focused on
surgical patients, including two studies in urology patients.
The meta-analysis indicated an overall reduction in symptomatic
urinary tract infection when antibiotic prophylaxis was given,
with a risk ratio of 0.45 (95% confidence interval 0.28 to 0.72)
compared with controls7 8 25-29 (fig 2⇓). The absolute reduction
of symptomatic urinary tract infection was 5.8% (31/665 (4.7%)
in the antibiotic prophylaxis group v 90/855 (10.5%) in the
control group). The number needed to treat to prevent one
symptomatic urinary tract infection was 17 (95% confidence
interval 12-30), with low heterogeneity (I2=16%).
We repeated the meta-analysis without the single
non-randomized study29; the risk ratio in the remaining six
studies was 0.45 (95% confidence interval 0.23 to 0.86) and not
different from the main analysis. The meta-analysis was also
repeated without the single unpublished trial28; the pooled risk
ratio was only slightly changed with 0.36 (0.22 to 0.59), again
pointing to a benefit of antibiotic prophylaxis. Finally, we
limited the analysis to studies conducted with surgical patients,
and the risk ratio remained unchanged (0.45; 0.29 to 0.70). In
contrast, when we pooled results from the two studies in mixed
hospital populations26 27 we found no significant advantage of
the intervention (0.44; 0.02 to 9.40).

There was significant variation in the duration of monitoring
after catheter removal, ranging from about four days in the study
of Pfefferkorn and colleagues7 to six weeks in the study by
Pinochet and colleagues.29 Also, various antimicrobial agents
were used (trimethoprim/sulfamethoxazole, ciprofloxacin,
nitrofurantoin, and a cephalosporin). The duration of prophylaxis
ranged from single dose administration8 26 to three day courses.29
No commercial reuse: See rights and reprints http://www.bmj.com/permissions

The study by Harding and colleagues also had an arm in which
patients were given a 10 day course of antibiotics26; this arm
was not considered in our meta-analysis because 10 days was
thought to represent pre-emptive treatment rather than
prophylaxis.

The funnel plot (fig 3⇓) suggests some publication bias, but
funnel plots can be difficult to interpret if the number of included
studies is small.16 In addition, asymmetrical funnel plots are not
sufficient proof of publication bias. Alternative explanations
for asymmetry include heterogeneity between studies with the
intervention fidelity or outcome assessment, as well as improved
standard of care in the control groups as routine management
evolves over time, which reduces the observed effect size. It is
also possible that an asymmetric funnel plot is the result of
chance alone.30

Discussion
In our meta-analysis of pooled data from seven studies (six of
which were randomized), there were significantly fewer
symptomatic urinary tract infections in patients receiving
prophylaxis during removal of a urinary catheter than in those
not receiving prophylaxis. Our finding in favor of antibiotic
prophylaxis, however, must be tempered by possible publication
bias toward positive studies, the limitations of the included
studies, and practical considerations about encouraging more
widespread antibiotic use.

Indwelling urinary catheters pose several risks to patients,
including urethral trauma, discomfort, and urinary tract
infection.31 In an era of increasingly constrained fiscal resources
and evolving antibiotic resistance, evidence based antimicrobial
prescribing is essential to promote antimicrobial stewardship.32
Unfortunately, there is no consensus on whether clinicians
should prescribe antibiotic prophylaxis to patients when an
indwelling urinary catheter is removed.

Current practice and variation in study
designs
Administration of prophylactic antibiotics at the time of removal
of a catheter might already be common practice, particularly
among urologists. In a survey by Wazait and colleagues,
conducted in 2004, antibiotic prophylaxis at the time of catheter
removal was practiced by 60% of respondents from various
medical specialties, and 40% of urologists indicated that they
used antibiotic prophylaxis in all patients.9 At the time of that
survey, however, little objective evidence was available to guide
management of bacteriuria after catheterization.26 27 Variation
in clinical practice is therefore not surprising given the
inconclusive evidence at that time.33 In addition, the survey by
Wazait and colleagues showed that there was heterogeneity in
the selection and duration of prophylactic antimicrobial agents.9
This variation in practice was also evident in the trials included
in our meta-analysis and precludes any formal recommendations
about choice of antibiotics or duration of treatment.
Ciprofloxacin and trimethoprim/sulfamethoxazole were the
most common drugs used, followed by nitrofurantoin (one study)
and cefotaxime (in the oldest study). Dose varied from single
dose to multiple day administration. Of note, current patterns
of antimicrobial resistance in uropathogens clearly argue against
the promotion of the use of both trimethoprim/ sulfamethoxazole
and ciprofloxacin.34-36 Nitrofurantoin, although its activity is
limited to the lower urinary tract, has broad activity against
Gram positive and Gram negative pathogens and an acceptable
toxicity profile and is not associated with important resistance
issues.28
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Implications of promoting antibiotic
prophylaxis and ideal target population
Antibiotic prophylaxis at the time of catheter removal could
lead to a dramatic increase in consumption of antibiotics in
hospital, based on the assumption that at least 20% of patients
are catheterized at some point during their hospital stay.37
Limitation of antibiotic prophylaxis to those patients who are
bacteriuric would be logistically challenging because all
catheterized patients would need to be screened, and the cost
of these screening cultures would be substantial. Certain
populations of patients, however, are most likely to benefit from
antibiotic prophylaxis on catheter removal, and prophylaxis
should be focused on these groups, as acknowledged in the AUA
guidelines.10 Future studies should attempt to identify specific
populations at risk for the development of urinary tract infections
after catheter removal that would be appropriate targets for
antibiotic prophylaxis. Also, the results of our meta-analysis
are largely driven by data on surgical patients and short term
urinary catheters. Only two studies included non-surgical
patients,26 27 and their pooled findings indicated no significant
difference between intervention and control group. Additional
studies should examine medical patients, including those living
in long term care facilities, who might be catheterized for longer.
Lastly, the benefit of preventing urinary tract infections should
be carefully weighed against the additional cost to the hospital
of prophylactic antibiotics, the potential for adverse antibiotic
effects, and the impact on resistance patterns of uropathogens.
Stochastic modeling and cost effectiveness analyses might be
ways to guide future decision making.
Limitations inherent to this meta-analysis include the potential
for publication bias, although we also included unpublished
abstracts in our search. Their quality grading was based on the
subjective assessment of two authors. Furthermore, the included
studies were distinctly different in design—with diverse
populations of patients, choices of antibiotics, durations of
prophylaxis, and a heterogeneous observation period after
removal of the catheter—so that standardized recommendations
are difficult to make. The largest included study was not
randomized but instead compared patients of surgeon A (who
gave prophylactic antibiotics) with patients of surgeon B (who
did not give prophylactic antibiotics); these surgeons’ practices
and techniques could have differed in many other ways. Also,
some of the studies did not use a placebo in the control arm,
and patients’ assessment and reporting of urinary symptoms
could have been affected by their knowledge of treatment status.
Lastly, only two of the included studies recorded information
on adverse events associated with the antibiotics, such as drug
toxicities, allergic reactions, or infections with Clostridium
difficile.7 27 None of the studies looked at the costs of antibiotic
prophylaxis or at emerging antimicrobial resistance. Clinicians
must assimilate these uncertainties when weighing advantages
and disadvantages of implementing antibiotic prophylaxis after
urethral catheterization.

of antibiotic administration are disadvantages that merit careful
review. From a public health standpoint, we should be careful
not to encourage antibiotic use when it might not be necessary.
The healthcare provider of a catheterized patient, however,
might consider antibiotic prophylaxis before catheter removal,
after taking individual risk factors into account. Future studies
should better characterize who is at risk of developing
symptomatic urinary tract infection after catheter removal
(whether bacteriuric or not) and then examine antibiotic
prophylaxis in those at greatest risk.
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Conclusions
This meta-analysis of available data indicates an overall benefit
of antibiotic prophylaxis at the time of removal of a urinary
catheter to prevent subsequent urinary tract infections. The
number needed to treat indicates that 17 patients would need to
receive prophylaxis to prevent one symptomatic urinary tract
infection. We know little, however, about the potential negative
consequences of implementing antibiotic prophylaxis in this
setting in a wider frame or indeed which types of patients would
be most likely to benefit. Increasing antimicrobial resistance,
healthcare costs for antibiotics, and the potential for side effects
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Tables
Table 1| Summary of studies on effect of antibiotic prophylaxis for urinary tract infections after removal of urinary catheter included in this

meta-analysis

Median duration of
catheterization (days)

Author

Year
published

Van Hees8

2011

Randomized,
placebo

91 general surgery

5/6

4.5

Pinochet29

2010

Prospective,
comparative
(patients of
surgeon A vs.
surgeon B)

713 radical
prostatectomy

11

7

Pfefferkorn7

2009

Randomized, no
placebo

205 abdominal
surgery

7

Brandenburg28

2006

Randomized,
placebo

288 general surgical

Wazait27

2004

Randomized,
placebo

Harding26

1991

Grabe25

1984

Design

Patients analyzed Antibiotics

Control

No of cases*
Antibiotic used

Antibiotics Control
1/36

Observation
period

Ciprofloxacin (n=31) or
TMP/SMX (n=24) x1
dose before removal

1/55

2 weeks

Ciprofloxacin (3 day
course starting day
before removal)

8/261

33/452 6 weeks

6.5

TMP/SMX (3 doses, first
before removal) or
ciprofloxacin

5/103

22/102 4 ±2 days after
catheter
removal

3

33

Nitrofurantoin (2 doses,
first before removal)

12/137

18/151 4 weeks

48 on medical and
surgical wards,
excluding
genitourinary surgery

3.8

3.6

Ciprofloxacin (4 doses,
two daily, first before
removal)

2/25

1/23

2 weeks

Randomized, no
placebo

79 women on
medical and surgical
wards with
bacteriuria

2.

2

TMP/SMX (single dose)

0/37

7/42

4 weeks
(prophylaxis) v
2 weeks (no
prophylaxis)

Randomized, no
placebo

96 transurethral
prostatectomy

1.9

1.8

Cefotaxime (3 doses, two
daily, first before
removal)

3/47

8/49

1 week

TMP/SMX=trimethoprim/sulfamethoxazole.
*Total was 31/665 (4.7%) in antibiotic group and 90/855 (10.5%) in control group.
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Table 2| Assessment of quality in studies on effect of antibiotic prophylaxis for urinary tract infections after removal of urinary catheter

included in this meta-analysis
Domain:

Selection bias Performance bias Attrition bias Detection bias

Van Hees8

0

0

0

0

Pinochet29

1

1

1

1/0

0

0

0/1

0

Pfefferkorn7
Brandenburg

1

1

1

0

Wazait27

0

0

0

0

Harding26

1

0

1

0

28

Grabe

25

Rating agreement (κ)

1

0

1

0

1.0

1.0

0.7

NA

NA=not applicable; 0=low risk; 1=high risk or uncertain.
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Figures

Fig 1 Selection of studies for meta-analysis of trials investigating antibiotic prophylaxis for urinary tract infections after
removal of urinary catheter

Fig 2: Forest plot of seven included studies with 1520 participants on effect of antibiotic prophylaxis on urinary tract infections
after removal of urinary catheter

Fig 3 Funnel plot of seven included studies with 1520 participants on effect of antibiotic prophylaxis on urinary tract infections
after removal of urinary catheter
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